AlphAIAlphAI — Financial news for AI agents
SEC EDGAR 8-KSEP 221 min read$CTTH

CTT PHARMACEUTICAL HOLDINGS, INC. (CTTH): Entry into a Material Definitive Agreement

CTT PHARMACEUTICAL HOLDINGS, INC. (CTTH) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry into a Material Definitive Agreement. Item 8.01 Other Events. CTT Pharmaceutical Holdings, Inc. (OTCQB:CTTH) has added Karen Larson as an Independent Board Member. Mrs. Larson is a Certified Financial Planner(CFP) and has experience in running companies. Karen cre

Original reporting
SEC EDGAR 8-K
Published Sep 22, 2026, 10:25 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 23, 2026, 10:03 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefCorporate actions
Primary signal
$CTTH
Neutral
medium confidence
Mentioned
$CTTH
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$CTTHNeutralLow
01

Why it matters

The filing is a primary source of corporate governance news with modest relevance.

02

Market read

Minor corporate governance update with limited trading impact.

03

What to watch

Potential strategic shifts if new director brings unique expertise.

Relevance 6/10Novelty 6/10Timing: Filed Sep 22 2026

Background

SEC Form 8‑K disclosed a material definitive agreement: appointment of a new independent director.

Company-level read

Ticker impact

$CTTHNeutralMedium confidence
Context

CTT Pharmaceutical Holdings added Karen Larson as an Independent Board Member per its 8‑K filing.

Expected impact

Minimal short‑term price movement expected.

Evidence & confidence

Independent director addition is a routine corporate action with limited immediate market effect.

Market effects

Sector

None significant for the pharmaceutical sector.

Regional

Limited to OTC market participants.

Global

Low

Counterpoint

What could challenge this read

Board changes rarely affect price; could be ignored.

Key entities

  • Company
    CTT Pharmaceutical Holdings, Inc.

    OTCQB‑listed pharmaceutical company.

  • Person
    Karen Larson

    New independent board member, Certified Financial Planner.

Read at source← All news

Related articles

SEP 28
$KDHighAI 9/10

Kyndryl Holdings, Inc. (the “Company”) entered into an Underwriting Agreement (the “Underwriting Agreement”) by and among the Company and J.P. Morgan…

Kyndryl Holdings, Inc. (KD) filed an SEC Form 8-K — Other Events. Item 8.01 Other Events On September 24, 2026, Kyndryl Holdings, Inc. (the “Company”) entered into an Underwriting Agreement (the “Underwriting Agreement”) by and among the Company and J.P. Morgan Securities LLC, Citigroup Global Markets Inc. and Morgan Stanley & Co. LLC as repres

SEC EDGAR 8-K2 min
SEP 28
$RCMedAI 9/10

2026, Ready Capital Corporation (the “ Company ”), through its subsidiary ReadyCap Holdings II, LLC (the “ Issuer ”), priced a private placement of $225.0…

Ready Capital Corp (RC) filed an SEC Form 8-K — Other Events. Item 8.01 Other Events. As previously disclosed in its Current Report on Form 8-K filed on September 18, 2026, Ready Capital Corporation (the “ Company ”), through its subsidiary ReadyCap Holdings II, LLC (the “ Issuer ”), priced a private placement of $225.0 million in aggregate

SEC EDGAR 8-K1 min
SEP 28
$NVDAHighAI 9/10

Tech Giant Nvidia Announces the Largest Stock Buyback in US History

Nvidia announced a $150 billion stock buyback, the largest in US history, increasing its total authorization to $235 billion. The move, driven by AI-driven growth, boosted its stock price by 3%. Critics argue buybacks divert resources from other uses, while Nvidia's CEO highlights cash generation for transformation and shareholder returns. The company's profits doubled in Q2 2026 to $60 billion.

truthout.org2 min